Auditor of Syngene's material subsidiary resigns
SYNGENE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts less than Nifty Smallcap 250 and 3.6 pts less than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
B S R & Co. LLP has resigned as Statutory Auditor of Syngene International's material subsidiary Syngene Scientific Solutions Limited, effective July 7, 2026. The resignation is due to mandatory rotation of the firm as auditors of the parent company Syngene under the Companies Act. Management wants to align subsidiary and holding company auditors. B S R had already completed the audit for FY ending March 2026.
Routine auditor change at subsidiary due to mandatory rotation. No governance concerns flagged. Neutral impact for shareholders.